Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132204) titled 'A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial on the efficacy and safety of MI078 capsules in the treatment of postpartum depression patients' on Sept. 10.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing An Ding Hospital, Capital Medical University

Condition: Postpartum depression

Intervention: Placebo group:MI078 Capsule Simulator

Recruitment Status: Not Recruiting

Phase: 3

Date of First Enrollment: 2026-09-10

Target Sample Size: Placebo group:100;Experimental group:100;

Countries of Recruitment: China

To know more, visit h...